Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ORIC Pharmaceuticals

Oric Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating

Oric Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.

Investors Business Daily

Oric Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark

Oric Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark

Oric Pharmaceuticals sees its Relative Strength Rating reach the 80-plus level.

Investors Business Daily

Oric Pharmaceuticals Stock Scores RS Rating Upgrade

Oric Pharmaceuticals Stock Scores RS Rating Upgrade

A Relative Strength Rating upgrade for Oric Pharmaceuticals shows improving technical performance.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks To Watch: Oric Pharmaceuticals Sees RS Rating Jump To 82

A Relative Strength Rating upgrade for Oric Pharmaceuticals shows improving technical performance.

Investors Business Daily

Oric Pharmaceuticals Shows Market Leadership With Jump To 93 RS Rating

Oric Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

ORIC: Working with Two Pharma Giants, Analysts See +100% Upside

ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.

12 Health Care Stocks Moving In Monday's Intraday Session

inkl

Read news from The Economist, FT, and more,
with one subscription

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For March 25, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 25, 2022

Upgrades For Aris Water Solutions Inc (NYSE:ARIS), Capital One upgraded the previous rating of Equal-Weight to Overweight. The stock has a 52-week-high of $19.16 and a 52-week-low of $10.06. At the end of the last trading period, Aris Water Solutions closed at $18.55.

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

Organisations

Intuitive Surgical

B of A Securities

Truist Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

Prostate Cancer

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play